ROMA (ITALPRESS) – The new research professions were at the centre of the second day of the event “Clinical Trials Day”, promoted by the Fondazione Policlinico Universitario Agostino Gemelli IRCCS, the Catholic University of the Sacred Heart and the Hospital Isola Tiberina-Gemelli Isola.
Indispensable for the proper conduct of clinical trials, the figures such as the Study Nurse and the Study Coordinator represent the operational and organizational focus of medical research, ensuring the quality of data, compliance with protocols and patient protection. Three awards were awarded today.
The first, for the best Study Nurse, entitled to one of the luminaries of Italian medicine, Professor Giovanni Exchangea, Scientific Director, as well as Director of the Oncological Gynaecology of the Gemelli Polyclinic, who died in February 2025, was assigned to Valeria Amatucci, who ranked first, followed to the second by Daniela Mercuri and finally to the third by Fabiana Bonetto.
The second prize, entitled to Ilaria Biagini, a young researcher of Policlinico, for the best Study Coordinator, went to Francesca Garibaldi, followed in second place by Cristina Graziani and in third by Martina Ventola. Each winner, as in the last edition, has been awarded a plate and a cash prize.
This year, Riccardo Mirarchi’s Award for Best Research Teams was added. Two different working groups have climbed on the stage which have distinguished themselves for excellence in the organization and management of Trials Profit and Trials No Profit. For Profit research, Dr. Vanda Salutari’s Team was awarded, and for No Profit, Dr. Franco Scaldaferri’s.
The two groups were given a plate and a package for a team building activity of a whole day for the entire staff of doctors, Study Nurses and study coordinators (about 30 people in each group).
“The aim we have is the development of effective and precise clinical trials. It is through the integration between artificial intelligence, digitization and new generation professional skills that we can build customized and targeted solutions for the challenges that await us. It is a technological and cultural evolution that we cannot afford to postpone: it means choosing whether to remain protagonists of international research or to leave the global markets of innovation. This is why we continue to invest in the new professions of research, which today we reward, and on the ability of our system to team between clinic, academy and enterprise”, says Antonio Gasbarrini, Ordinary of Internal Medicine of the Catholic University and Scientific Director of the Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
“The clinical trial today requires a high competitiveness and a rapidity of action that until a few years ago were unthinkable,” explains Vincenzina Mora, Coordinator of the event and Director of Operation of the Research of the University Polyclinic Foundation Agostino Gemelli IRCCS. “To keep up with global innovation, it is not enough to follow the protocols properly, it is necessary to rethink the workflows. The research is going at a very high speed and to keep up it is necessary to simplify the bureaucracy, to speed up the activation phase and to reduce the enrollment time. The requirements of centres that can conduct clinical studies are increasingly stringent and that is why it is necessary to network to bring new therapeutic opportunities to all citizens. Participating in a clinical Trial means taking advantage today of a therapy of the future. It is here that figures such as the Study Nurse and the Study Coordinator become decisive: they translate technological innovation into everyday practice, ensuring that every new tool is translated into a concrete benefit for those who participate in experiments.”.
-Photos print office Policlinico Gemelli-
(ITALPRESS).
